Log in or Sign up for Free to view tailored content for your specialty!
Diabetes Education News
Homelessness during pregnancy tied to poor maternal, infant health outcomes
Women who reported experiencing homelessness during the year before giving birth were more likely to have delayed prenatal care and develop hypertension, diabetes and postpartum depression vs. women who reported adequate housing, data show.
Q&A: Time-restricted eating can have a 'meaningful impact' on metabolic syndrome
Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health complications, according to an expert.
Log in or Sign up for Free to view tailored content for your specialty!
Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years
SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.
Semaglutide cuts major kidney complications risk for adults with type 2 diabetes, CKD
SAN DIEGO — Semaglutide was associated with lower risk for major kidney complications for adults with type 2 diabetes and chronic kidney disease without regard to baseline kidney function, data show.
Dysregulated metabolic pathways in late pregnancy tied to higher type 2 diabetes incidence
SAN ANTONIO — Dysregulated amino and fatty acid metabolism during late pregnancy was tied to elevated incidence of type 2 diabetes among women with a history of gestational diabetes, according to a presentation at ObesityWeek.
FDA panel votes against sotagliflozin for glucose control in type 1 diabetes, CKD
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended not approving sotagliflozin for glucose control as an adjunct to insulin in adults with type 1 diabetes and CKD.
Frequent, persistent hot flashes associated with 50% increased risk for diabetes
Women with frequent and persistent hot flashes and night sweats during the menopause transition are at increased risk for developing diabetes compared with women who do not experience vasomotor symptoms, researchers reported.
5 years after rejection, sotagliflozin for type 1 diabetes gets new FDA panel hearing
Five years after receiving a complete response letter from the agency, Lexicon Pharmaceuticals brought sotagliflozin back before an FDA advisory panel to seek an indication to treat patients with type 1 diabetes and chronic kidney disease.
Continuous glucose monitor sensors now approved to be worn during imaging procedures
Abbott announced that the FDA has removed the contraindication for its continuous glucose monitoring sensors to be used during imaging procedures.
Approaches to holistic obesity treatment and identifying healthful behaviors
BOSTON — Behavioral modification with diet and exercise demonstrated similar weight-loss benefits vs. other pharmaceutical and surgical approaches to obesity management, but patients must remain adherent, a speaker reported.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read